Biospecimen CollectionReturn of ResultsSurvey Administration
Biospecimen Collection: Undergo collection of tissue, blood, saliva, and stool samples
Return of Results: Receive results
Survey Administration: Surveys and Interviews
Study summary
This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast, and colon. American Indians with cancer may also live for less time than people from other population groups who have been treated for the same cancer. Damage to the cells of the body, acquired as people live, grow older, and are exposed to the environment, causes genetic changes in cells that can lead to cancer. This study may help researchers learn how these genetic changes in cells cause cancer and understand how and why cancer is arising in American Indians in the Southwest. This may help better prevent and treat cancer in the future.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* The PE-CGS Research Center is only recruiting and sequencing tumors for adult-onset cancers (patients and survivors) among the American Indian Tribes, Nations, and Pueblos of New Mexico and adjacent states
* Male or female adults (18 years) or older
* Cancer patient undergoing active treatment or a cancer survivor
* Self-identify as American Indian
Exclusion Criteria:
* Cognitively impaired
* Adults unable to consent for themselves
* Individuals who are not yet adults
* Prisoners
Primary outcome measure(s)
Total Enrolled Participants — Up to 18 months Number and percent of eligible participants enrolled and consented
Data participation rate — Up to 18 months Number and percent of eligible participants who complete, or partially complete, baseline and follow up data collection of epidemiological assessments and follow up data collection of epidemiological assessments
Biospecimen participation rate — Up to 18 months Number and percent of enrolled participants for whom biospecimens are collected and processed for genomic analysis
Rate of comprehensive genomic analysis completion — Up to 18 months Number and percent of participants/samples that undergo successful comprehensive genomic and bioinformatic analysis
Rate of successful return of clinical genetic/genomic results — Up to 18 months Number and percent of participants who elect to receive clinical genetic/genomic results and incidental findings
Rate of new threptic intervention as a result of participation — Up to 18 months Number and percent of participants/patients whose clinical genomic data facilitates therapeutic intervention
Rate of Preparatory and Optimization Phase completion — Up to 18 months Successful completion of the Preparatory and Optimization Phases
Trial sites (1)
Facility
City
Region
Status
University of New Mexico Comprehensive Cancer Center
Albuquerque
New Mexico
Recruiting
More New Mexico Cancer Research Alliance trials in Mexico
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.